article thumbnail

Atherothrombotic Outcomes After Sodium‐Glucose Cotransporter 2 Inhibitors Versus Dipeptidyl Peptidase‐4 Inhibitors in Patients With Type 2 Diabetes: A Territory‐Wide Retrospective Cohort Study

Journal of the American Heart Association

The primary outcome was atherothrombotic major adverse cardiovascular events as a composite outcome of cardiovascular mortality, nonfatal stroke, and nonfatal myocardial infarction. Patients were propensity matched in a 1:1 ratio using a caliper distance of 0.2 without replacement.

article thumbnail

Abstract WMP98: Elevated Troponin With and Without Myocardial Infarction in Acute Ischemic Stroke

Stroke Journal

We examined whether etiology of elevated cTN after AIS modulates the risk of death using a large population-based study in the Greater Cincinnati Northern Kentucky (GCNK) region.Methods:Using well-validated methods, all hospitalized AIS cases in the GCNK region were collected and adjudicated in 2015.

article thumbnail

Effectiveness of polypill for primary and secondary prevention of cardiovascular disease: a pragmatic cluster-randomised controlled trial (PolyPars)

Heart BMJ

The primary outcome was the first occurrence of major cardiovascular events defined as a composite of hospitalisation for acute coronary syndrome (non-fatal myocardial infarction and unstable angina), fatal myocardial infarction, non-fatal and fatal stroke, sudden death and heart failure.

article thumbnail

Impact of atrial fibrillation on the risk of major adverse cardiac events following coronary revascularisation

Open Heart

Methods We used the University of Ottawa Heart Institute Revascularisation Registry to identify patients who underwent revascularisation between August 2015 and March 2020, who were prospectively followed for an average of one year. We conducted a retrospective cohort study analysing the association between AF and clinical outcomes.

article thumbnail

Study Examines Noncigarette Tobacco Use and Cardiovascular Outcomes

DAIC

Users of smokeless tobacco products had increased risk for myocardial infarction and mortality due to coronary heart disease. tim.hodson Tue, 01/14/2025 - 10:11 Jan.

article thumbnail

National A-Fib Numbers Higher Than Previously Thought

DAIC

percent of the patients treated between 2005 and 2009 to 6.82% of the patients treated between 2015 and 2019. The study appears Sept. 11 in the Journal of the American College of Cardiology JACC. About 2 million of these people had been diagnosed with A-Fib, and the numbers grew over time, rising from 4.49

article thumbnail

Improved Clinical Outcomes with Intravascular Imaging-Guided PCI: Impact of Standardized Optimization Protocols

Cardiology Update

The RENOVATE-COMPLEX-PCI trial demonstrated the superiority of IVI-guided PCI over angiography-guided PCI in patients undergoing complex procedures, showing significant reductions in cardiac death, target vessel-related myocardial infarction (MI), and target vessel revascularization. vs 6.7%; HR: 0.77; 95% CI: 0.61-0.97;